A calcium examination
executed with the help of a CT scanner appears to give insight that particular individuals
are at average threat of heart diseases will have a heart attack or stroke, according
to the study. The examination to identify
coronary calcium can aid doctors uncover whether the patients should consume
cholesterol-lowering drugs
to decrease their cardiovascular threats.
800x600
Normal
0
false
false
false
EN-PH
X-NONE
X-NONE
A calcium examination
executed with the help of a CT scanner appears to give insight that particular individuals
are at average threat of heart diseases will have a heart attack or stroke, according
to the study. The examination to identify
coronary calcium can aid doctors uncover whether the patients should consume
cholesterol-lowering Canadian drugs
to decrease their cardiovascular threats, the study authors clarified.
The study, released
in the Aug. 19 issue of The Lancet, wanted to identify whether an
examination of calcium in the arteries is more beneficial at assessing threat
than a blood test which evaluates levels of C-reactive protein, and thus avoid
taking and buying Diovan for their
blood pressure concerns brought by their heart problems. The study researchers monitored 2,083 individuals
for six years. They identified that 13 percent of those with the maximum levels
of calcium in their arteries had a heart attack or stroke within that time span.
But just 2 percent of those with excessive levels of C-reactive protein and no
calcium upsurge had a heart attack or stroke.
Not all are required
to undergo a calcium examination, according lead study author Dr. Michael J.
Blaha, a cardiology fellow at the Johns Hopkins University School of Medicine. But,
he said in a Hopkins news release, "we believe looking for calcification
in coronary vessels in certain patients makes sense in order to predict who may
benefit from statin therapy, because the test gets right to the heart of the
disease we want to treat."
"Our data
support recent American Heart Association guidelines, which say it is
reasonable to order a coronary calcium scan for adults who are considered to be
at intermediate risk of a heart attack over the next 10 years. A high coronary
calcium score would indicate that statin therapy would likely be a useful
strategy to lower that person's cardiovascular risk," study
co-investigator Dr. Roger Blumenthal, director of the Ciccarone Center for the
Prevention of Heart Disease at Johns Hopkins University, stated in the news
release.
Remarking on the research,
cardiologist Dr. Vijay Nambi, an assistant professor at Baylor College of
Medicine, stated that majority of insurance companies doesn’t include the
calcium exams, which is valued from $200 to $400. "Sometimes people have
to pay for it out of pocket," said Nambi, who thinks it's a useful test.
"It helps physicians in a lot of respects."
Exam findings can
also assist patients in making assessments when they're concerned regarding
taking anticholesterol Canadian
prescription drugs , Nambi further added.
are at average threat of heart diseases will have a heart attack or stroke, according
to the study. The examination to identify
coronary calcium can aid doctors uncover whether the patients should consume
cholesterol-lowering drugs
to decrease their cardiovascular threats.
800x600
Normal
0
false
false
false
EN-PH
X-NONE
X-NONE
A calcium examination
executed with the help of a CT scanner appears to give insight that particular individuals
are at average threat of heart diseases will have a heart attack or stroke, according
to the study. The examination to identify
coronary calcium can aid doctors uncover whether the patients should consume
cholesterol-lowering Canadian drugs
to decrease their cardiovascular threats, the study authors clarified.
The study, released
in the Aug. 19 issue of The Lancet, wanted to identify whether an
examination of calcium in the arteries is more beneficial at assessing threat
than a blood test which evaluates levels of C-reactive protein, and thus avoid
taking and buying Diovan for their
blood pressure concerns brought by their heart problems. The study researchers monitored 2,083 individuals
for six years. They identified that 13 percent of those with the maximum levels
of calcium in their arteries had a heart attack or stroke within that time span.
But just 2 percent of those with excessive levels of C-reactive protein and no
calcium upsurge had a heart attack or stroke.
Not all are required
to undergo a calcium examination, according lead study author Dr. Michael J.
Blaha, a cardiology fellow at the Johns Hopkins University School of Medicine. But,
he said in a Hopkins news release, "we believe looking for calcification
in coronary vessels in certain patients makes sense in order to predict who may
benefit from statin therapy, because the test gets right to the heart of the
disease we want to treat."
"Our data
support recent American Heart Association guidelines, which say it is
reasonable to order a coronary calcium scan for adults who are considered to be
at intermediate risk of a heart attack over the next 10 years. A high coronary
calcium score would indicate that statin therapy would likely be a useful
strategy to lower that person's cardiovascular risk," study
co-investigator Dr. Roger Blumenthal, director of the Ciccarone Center for the
Prevention of Heart Disease at Johns Hopkins University, stated in the news
release.
Remarking on the research,
cardiologist Dr. Vijay Nambi, an assistant professor at Baylor College of
Medicine, stated that majority of insurance companies doesn’t include the
calcium exams, which is valued from $200 to $400. "Sometimes people have
to pay for it out of pocket," said Nambi, who thinks it's a useful test.
"It helps physicians in a lot of respects."
Exam findings can
also assist patients in making assessments when they're concerned regarding
taking anticholesterol Canadian
prescription drugs , Nambi further added.
No comments:
Post a Comment